Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 129,274 shares at $13.34 ($1.7M) on 2024-03-04, disclosed to the SEC on 2024-03-05.
Scheduled sale ($1.7M) by Executive VP, European Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.34 | 33,512 | $447K | 25.9% |
| 2 | $13.34 | 33,512 | $447K | 25.9% |
| 3 | $13.34 | 62,250 | $830K | 48.2% |
| Total | $13.34 avg | 129,274 | $1.7M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |